FDA Commissioner Scott Gottlieb wants the tech industry to agree to reduce opioid availability online and to meet again in a year to review progress.

The FDA commissioner aimed particular criticism at giant pharmacy benefit managers for their role in hindering access to less-expensive versions of high-cost drugs.

Proposals include making sure seniors in Medicare benefit from discounts that middlemen negotiate with drugmakers, establishing a spending cap on out-of-pocket prescription costs, and potentially making generic drugs free for low-income seniors.

President Donald Trumps head of the Centers for Disease Control and Prevention resigned amid a scandal surrounding investments she made in a tobacco company shortly after taking the helm of the agency.

The U.S. Senate confirmed Alex Azar to head the Department of Health and Human Services, setting a permanent replacement for Tom Price four months after he was ousted amid a scandal over his travel.

President Donald Trumps pick to lead the U.S. Health and Human Services Department is likely to face questions on drug prices and Obamacare when he faces senators at his second hearing on Capitol Hill.

Getting more low-cost medicines to pharmacy shelves could strain a global supply chain already confronting questions bout quality and safety.

Two bipartisan measures designed to bring down Obamacare insurance premiums will be left out of a year-end spending bill after Republicans agreed with the party leaders to let debate slip into next month.